Covid-19: Novavax vaccine shows 89% efficacy in UK trials
The vaccine is the first to show in trials that it is effective against the UK variant of the virus. …
Kate Bingham, who used to chair the UK’s Vaccine Taskforce, said the reason the UK had a good supply of vaccines compared with other countries was because of its ability to get clinical trials completed quickly and at a high standard through the NHS’s registry – with some 400,000 volunteers signing up “before the US even started their Phase 3 studies”.
About The Author
